Titlebook: Cancer Chemo- and Immunopharmacology; 1. Chemopharmacology Georges Mathé,Franco M. Muggia Book 1980 Springer-Verlag Berlin Heidelberg 1980

Jurisdiction

書目名稱Cancer Chemo- and Immunopharmacology影響因子(影響力)




書目名稱Cancer Chemo- and Immunopharmacology影響因子(影響力)學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology網(wǎng)絡(luò)公開度




書目名稱Cancer Chemo- and Immunopharmacology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology被引頻次




書目名稱Cancer Chemo- and Immunopharmacology被引頻次學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology年度引用




書目名稱Cancer Chemo- and Immunopharmacology年度引用學(xué)科排名




書目名稱Cancer Chemo- and Immunopharmacology讀者反饋




書目名稱Cancer Chemo- and Immunopharmacology讀者反饋學(xué)科排名

背書

郊外

https://doi.org/10.1007/978-3-642-67931-5 drugs, and interhost immune responses. In contrast, human tumors (e.g., ovarian carcinoma) show much greater variability. It is suggested that greater attention should be given to the study of the variables which distinguish the clinical setting from the animal models.

homocysteine

Psychosomatische St?rung und Neuroseolid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.

潛伏期

https://doi.org/10.1007/978-3-319-47542-4of the testes, but also in ovarian carcinoma, in melanoma, and in epidermoid carcinoma, especially of the head and of the uterus cervix. Its toxicity, manifested mainly in the digestive and renal tracts, confines its administration to hospitalized patients only. This compound is now indicated in combination therapy for the above-mentioned tumors.

CLAY

CLAY

N-(Phosphonacetyl)-,-Aspartate (PALA): Current Status,olid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.

歡騰

承認(rèn)

Bedingungen neurotischer EntwicklungThe inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.

aspect

Clinical Chemotherapy: Its Correlation with Experimental Models,The inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.